Directory
>
Chris Varma
Chris Varma
Co-Founder, Chairman & CEO | Revolution Medicines
Portola Valley, California, United States
Chris Varma
Summary
Chris Varma is a seasoned entrepreneur and investor in the life sciences sector, currently serving as Co-Founder, Chairman, and CEO of Frontier Medicines, which focuses on developing therapies for difficult-to-target proteins. With a rich history in biotechnology, he previously led Blueprint Medicines as President and CEO, guiding it through its initial public offering process. Chris's career spans prestigious roles including Venture Partner at MPM Capital and Entrepreneur-In-Residence at Third Rock Ventures, where he co-founded Warp Drive Bio. His academic credentials are impressive, holding multiple degrees from Stanford University and a Ph.D. from the Harvard-MIT Health Sciences & Technology program. He is actively involved in the Harvard Medical School Discovery Council and the International Vaccine Institute board, reflecting his commitment to advancing medical research and innovation. Chris's diverse experience in both startups and established companies positions him as a key player in the pharmaceutical industry.
Chris Varma
Work Experience
Co-Founder, Chairman & CEO at
Frontier Medicines
March 2018 - Present
Member of the Discovery Council at
Harvard University
January 2011 - Present
Co-Founder at
Revolution Medicines
September 2010 - Present
Venture Partner at
MPM BioImpact
January 2017 - April 2019
Member of the Leadership Board of McGovern Institute for Brain Research at
Massachusetts Institute of Technology
January 2009 - January 2018
Co-Founder, President & CEO at
Blueprint Medicines
September 2010 - May 2013
Entrepreneur-In-Residence at
Third Rock Ventures
January 2010 - January 2012
Partner at
Flagship Pioneering
July 2007 - July 2010
Director at
Novartis
January 2004 - January 2007
Chris Varma
Education
Frequently Asked Questions about Chris Varma
What is Chris Varma email address?
Chris Varma's primary email address is ***********@harvard.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Chris Varma work for?
Chris Varma is a Co-Founder, Chairman & CEO at Revolution Medicines, a company specializing in Commercial physical research.
Where Chris Varma graduated from?
Chris Varma holds a degree in Health Sciences & Technology / Biomedical Sciences from Massachusetts Institute of Technology.
How can I directly contact Chris Varma?
To contact Chris Varma directly, you can use the email address ***********@harvard.edu. Complete contact information is available upon registration with Muraena.
Who is Chris Varma?
Chris Varma is a seasoned entrepreneur and investor in the life sciences sector, currently serving as Co-Founder, Chairman, and CEO of Frontier Medicines, which focuses on developing therapies for difficult-to-target proteins. With a rich history in biotechnology, he previously led Blueprint Medicines as President and CEO, guiding it through its initial public offering process. Chris's career spans prestigious roles including Venture Partner at MPM Capital and Entrepreneur-In-Residence at Third Rock Ventures, where he co-founded Warp Drive Bio. His academic credentials are impressive, holding multiple degrees from Stanford University and a Ph.D. from the Harvard-MIT Health Sciences & Technology program. He is actively involved in the Harvard Medical School Discovery Council and the International Vaccine Institute board, reflecting his commitment to advancing medical research and innovation. Chris's diverse experience in both startups and established companies positions him as a key player in the pharmaceutical industry.
Chris`s contact details
***********@harvard.edu
*****@frontiermeds.com
***********@dfusetech.com
Colleagues
VP, Corporate Development
Vice President, FP&A and Strategy
Vice President - Clinical Data Science, Analytics, & Systems
Sr. Vice President, Pharmaceutical Development and Manufacturing
SVP, Medicinal Chemistry
Vice President Commercial Development
Vice President, Head of Quantitative Sciences
VP, Head of Information Security
Former SVP, Investor Relations & Corporate Affairs
CFO at REVOLUTION Medicines